Bg pattern

CEFIXIME MABO 200 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CEFIXIME MABO 200 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

CefiximeMabo200 mg film-coated tablets EFG

CefiximeMabo400 mg film-coated tablets EFG

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

.

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Cefixime Mabo and what is it used for
  2. What you need to know before you take Cefixime Mabo
  3. How to take Cefixime Mabo
  4. Possible side effects
  5. Storage of Cefixime Mabo

6. Contents of the pack and further information

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

1. What is Cefixime Mabo and what is it used for

Cefixime Mabo film-coated tablets (called Cefixime Mabo in this leaflet) contain a medicine called cefixime, which belongs to a group of antibiotics called ‘cephalosporins’, used to treat infections caused by bacteria.

Informative text about the use of antibiotics and precautions about their administration and disposal

Cefixime Mabo is used to treat:

  • Middle ear infection
  • Infection that causes sudden worsening of long-term bronchitis
  • Uncomplicated acute bladder infection
  • Uncomplicated kidney infection
  • Acute throat infection caused by bacteria
  • Uncomplicated acute gonorrhea

If you need more information about your condition, ask your doctor.

2. What you need to know before you take Cefixime Mabo

Do not takeCefixime

  • If you are allergic to cefixime or any of the other ingredients of this medicine (listed in section 6).
  • If you are allergic to any other type of cephalosporin antibiotic.
  • If you have had a severe allergic reaction to penicillin or any other beta-lactam antibiotic.

Do not take this medicine if you meet any of the above criteria. If you are not sure, talk to your doctor or pharmacist before taking Cefixime Mabo.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Cefixime Mabo if:

  • you have had colitis before
  • you have kidney problems
  • the person taking this medicine is under 12 years of age.

If you are not sure if the above applies to you, consult your doctor or pharmacist before taking this medicine.

Cefixime Mabo is not suitable for everyone.

Before takingCefixime Mabo tell your doctor if:

  • you are allergic to penicillin or any other beta-lactam antibiotic.

An allergic reaction can include a skin rash (hives), itching, difficulty swallowing or breathing, or swelling of the face, lips, throat, and tongue. Not everyone who is allergic to penicillins is also allergic to cephalosporins. But you should be especially careful if you have ever had an allergic reaction to any penicillin, because you may also be allergic to this medicine. If a patient has a severe allergic reaction or anaphylaxis (a severe allergic reaction that causes difficulty breathing or dizziness) after taking Cefixime Mabo, treatment should be discontinued and appropriate treatment should be provided.

  • you are taking other medicines that are harmful to the kidneys. Also, inform your doctor if you have any kidney problems. Your doctor may perform certain tests periodically to measure kidney function during treatment.
  • you have had severe or persistent diarrhea with stomach pain or cramps during treatment with Cefixime Mabo or after, stop taking this medicine and contact your doctor immediately. You will not be able to take medicines that slow down or stop bowel movements.

If you experience a syndrome known as DRESS (skin rash with eosinophilia and systemic symptoms), Stevens-Johnson syndrome, or a skin reaction known as toxic epidermal necrolysis (see section 4. Possible side effects) while taking Cefixime Mabo, stop taking this medicine and contact your doctor immediately.

Treatment with a cycle of Cefixime Mabo may temporarily increase the likelihood of developing infections caused by other types of germs that cefixime does not affect. For example, you may develop oral candidiasis (an infection caused by a yeast-like fungus called Candida).

Taking Cefixime Mabo with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

In particular, tell your doctor or pharmacist if you are taking:

  • Medicines that harm the kidneys, such as
    • Antibiotics like aminoglycosides, polymyxin B, colistin, and viomycin
    • Medicines that increase the amount of urine your body produces (diuretics), such as ethacrynic acid or furosemide.
  • Nifedipine (a medicine used to treat high blood pressure or heart problems)
  • Anticoagulants (medicines that prevent blood clotting) such as warfarin in some patients. Cefixime can cause coagulation problems and may increase the time it takes for blood to clot.

Interference with laboratory tests- If you have a blood or urine test, tell your doctor that you are taking Cefixime, because cefixime can alter the results of some of these tests.

  • Cefixime can alter the results of some urine sugar tests (such as Benedict or Fehling tests). If you have diabetes and have regular urine tests, tell your doctor, because other tests may need to be used to control diabetes while taking this medicine.
  • Cefixime can alter the results of some tests to measure ketones in the urine. Tell your doctor that you are taking Cefixime, because other tests may need to be used.
  • Cefixime can alter the results of a blood test to detect antibodies called the direct Coombs test.

Taking CefiximeMabowith food and drinks

Cefixime Mabo can be taken with or without food. The tablet should be swallowed with a glass of water.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Cefixime can cause dizziness. If you are affected, do not drive or operate machinery.

3. How to take Cefixime Mabo

Follow the instructions for administration of this medicine exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.

These tablets should be taken orally. You should try to take this medicine at approximately the same time every day. The recommended dose is:

Adults and adolescents over 12 years:1 x 400 mg per day as a single dose or 2 x 200 mg daily dose

Patients with kidney problems

If you have severe kidney problems or are undergoing dialysis, your doctor will reduce your dose.

Your doctor will calculate the correct dose for you based on the results of blood or urine tests that measure kidney function. The available data on the use of cefixime in children and adolescents with kidney problems are insufficient. Therefore, cefixime is not recommended for use in these patients.

Elderly patients

No dose adjustment is necessary for elderly patients with normal kidney function.

Adolescents from 12 years of age onwards

Adolescents from 12 years of age onwards can receive the same dose as adults.

Children under 12 years of age

The tablet formulation is not suitable for children under 12 years of age. You should ask your doctor for more information.

If you take moreCefiximeMabothan you should

If you or your child have taken more of this medicine than you should, tell your doctor or contact the nearest emergency department immediately. Take your tablets with you, even if there are no tablets left in the pack, so that the doctor knows exactly what you have taken.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service (Tel. 91 562 04 20), indicating the medicine and the amount ingested.

If you forget to take CefiximeMabo

If you forget to take a tablet, take it as soon as you remember. But if it is almost time for the next dose, do not take it and resume your normal schedule. Do not take a double dose to make up for forgotten doses.

If you stop taking CefiximeMabo

Do not stop taking Cefixime Mabo just because you feel better. It is important that you take this medicine until you finish the cycle that your doctor has prescribed. If you stop taking it too soon, the infection may come back. If the person being treated continues to feel unwell at the end of the treatment cycle prescribed by their doctor or worsens during treatment, they should inform their doctor.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects are important and may require immediate action if you experience them. Stop taking CefiximeMaboand see your doctor immediately if you experience the following symptoms:

Very rare (may affect up to 1 in 10,000 people):

  • Watery and severe diarrhea, which may also be bloody
  • Sudden severe allergic reactions (anaphylactic shock) such as skin rash or hives, itching, swelling of the face, lips, tongue, or other parts of the body, tightness in the chest, wheezing, or fainting.
  • Severe skin disease with blisters on the skin, mouth, eyes, and genitals (Stevens-Johnson syndrome, toxic epidermal necrolysis) (see section 2. What you need to know before you take Cefixime Mabo - Warnings and precautions).

Frequency not known(cannot be estimated from the available data):

  • Severe skin rash, fever, enlarged lymph nodes, and increased number of a type of white blood cell called eosinophils (DRESS syndrome) (see section 2. What you need to know before you take Cefixime Mabo - Warnings and precautions).

The following side effects have also been reported:

Common(may affect up to 1 in 10 people):

  • Diarrhea

Uncommon(may affect up to 1 in 100 people):

  • Headache
  • Nausea
  • Vomiting
  • Abdominal pain (in the stomach), pain, indigestion
  • Changes in blood tests that measure liver function
  • Skin rash

Rare(may affect up to 1 in 1,000 people):

  • Increased risk of infection by germs that cefixime does not affect. For example, oral candidiasis.
  • Increased number of a type of white blood cell called eosinophils
  • Allergic reaction
  • Lack of appetite
  • Dizziness
  • Flatulence (gas)
  • Itching of the skin
  • Inflammation of the mucous membrane that lines the mouth and/or other internal surfaces
  • Fever
  • Changes in blood tests that measure kidney function

Very rare(may affect up to 1 in 10,000 people):

  • Reduced number of various blood cells (symptoms may include fatigue, new infections, and a tendency to bruise or bleed)
  • Allergic reaction characterized by skin rash, fever, joint pain, and enlargement of certain organs
  • Restlessness and increased activity
  • Liver problems, such as jaundice (yellowing of the skin or the whites of the eyes)
  • Kidney inflammation

Frequency not known(cannot be estimated from the available data):

  • Increased platelet count (thrombocytosis)
  • Reduced number of a type of white blood cell called neutrophils (neutropenia)
  • Indigestion
  • Skin rash or skin lesions with a pink/red ring and a pale center, which can be itchy, scaly, or fluid-filled. The rash usually appears on the palms of the hands or the soles of the feet. They can be signs of a severe allergy to the medicine, known as "erythema multiforme".
  • A brain condition with symptoms including seizures (convulsions), feeling confused, feeling less alert or aware than usual, unusual muscle movements, or stiffness. This can be a condition called encephalopathy. This side effect is more likely if you have taken an overdose or if you already have a kidney problem.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of CEFIXIMA MABO

Keep this medicine out of the sight and reach of children.

Store below 25°C. Do not refrigerate or freeze.

Do not use this medicine after the expiry date which is stated on the carton after {CAD}. The expiry date is the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and further information

  • Composition of Cefixime Mabo
  • The active substance is cefixime. Each film-coated tablet contains 200 mg or 400 mg of cefixime (as trihydrate).
  • The other ingredients are: Calcium hydrogen phosphate dihydrate; Pregelatinized maize starch, Microcrystalline cellulose, Magnesium stearate, Hypromellose, Titanium dioxide, Macrogol 3350, Triacetin

Appearance of the product and pack contents

Cefixime Mabo 200 mg film-coated tablets EFG

Film-coated tablets, convex, circular (10.0 to 10.4 mm in diameter), white to light cream in color, engraved with "A 11" on one side and smooth on the other.

Cefixime Mabo 200 mg film-coated tablets are supplied in PVC-Aclar/Aluminum and PVC-PVdC/Aluminum blisters containing 1, 5, 6, 7, 8, 10, 12, 14, 20, and 21 film-coated tablets.

Cefixime Mabo 400 mg film-coated tablets EFG

Film-coated tablets, oblong (18.7 to 19.1 mm long and 8.4 to 8.8 mm wide), white to light cream in color, with a score line on one face of the tablet, engraved with "A" and "10" on one side and smooth on the other.

Cefixime Mabo 400 mg film-coated tablets are supplied in PVC-Aclar/Aluminum and PVC-PVdC/Aluminum blisters containing 1, 3, 5, 6, 7, 8, and 10 film-coated tablets.

The tablet can be divided into equal doses.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

MABO-FARMA S.A.

Calle Rejas 2, planta 1

28821 Coslada (Madrid)

Spain

Manufacturer

Pharmadox Healthcare Ltd.

KW20A Kordin Industrial Park,

Paola PLA3000, Malta

This medicine is authorized in the Member States of the European Economic Area under the following names:

Portugal:Cefixime Nectar

Austria:Cefixime Nectar

Bulgaria:Cefixime Nectar

Germany:Cefixime Nectar

Spain:Cefixime Mabo

France:Cefixime Neclife

Hungary:Cefixime Nectar

Romania:Cefixime Nectar

Slovakia:Cefixime Nectar

:

Date of last revision of thisleaflet:September 2018

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/

Online doctors for CEFIXIME MABO 200 mg FILM-COATED TABLETS

Discuss questions about CEFIXIME MABO 200 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CEFIXIME MABO 200 mg FILM-COATED TABLETS?
CEFIXIME MABO 200 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CEFIXIME MABO 200 mg FILM-COATED TABLETS?
The active ingredient in CEFIXIME MABO 200 mg FILM-COATED TABLETS is cefixime. This information helps identify medicines with the same composition but different brand names.
How much does CEFIXIME MABO 200 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for CEFIXIME MABO 200 mg FILM-COATED TABLETS is around 8.04 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures CEFIXIME MABO 200 mg FILM-COATED TABLETS?
CEFIXIME MABO 200 mg FILM-COATED TABLETS is manufactured by Mabo Farma S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CEFIXIME MABO 200 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CEFIXIME MABO 200 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CEFIXIME MABO 200 mg FILM-COATED TABLETS?
Other medicines with the same active substance (cefixime) include CEFIXIME CODAL 400 mg FILM-COATED TABLETS, CEFIXIME MABO 400 mg FILM-COATED TABLETS, CEFIXIME NECLIFE 100 mg/5 ml ORAL SUSPENSION POWDER. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media